We are live on
!
Find out more
CH
CVI Holdings Portfolio holdings
AUM
$116M
1-Year Est. Return
5.68%
This Fund
S&P 500
This Quarter
Est. Return
+172.63%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$270M
AUM Growth
+$241M
(+847%)
Cap. Flow
+$154M
Cap. Flow
% of AUM
57.06%
Top 10 Holdings %
Top 10 Hldgs %
65.79%
Holding
91
New
53
Increased
2
Reduced
3
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NKLA
Nikola Corporation Common Stock
NKLA
|
+$16.1M |
| 2 |
HECCU
Hudson Executive Investment Corp. Units
HECCU
|
+$12.2M |
| 3 |
Tencent Music
TME
|
+$11.8M |
| 4 |
Innovative Industrial Properties
IIPR
|
+$11.5M |
| 5 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
+$11.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enlivex Ltd
ENLV
|
+$1.96M |
| 2 |
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
|
+$1.21M |
| 3 |
BXRX
Baudax Bio, Inc. Common Stock
BXRX
|
+$1.07M |
| 4 |
Imunon
IMNN
|
+$1.03M |
| 5 |
Phio Pharmaceuticals
PHIO
|
+$637K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.03% |
| 2 | Consumer Discretionary | 15.45% |
| 3 | Communication Services | 10.78% |
| 4 | Real Estate | 4.6% |
| 5 | Financials | 2.44% |
Similar funds
EL
YSP
GIM
FWM
CPG
WCM
ETIA
RCM
CVI Holdings's Q2 2020 Portfolio in Review
As of Q2 2020, CVI Holdings held 91 positions worth $270M, up 847% from $28.5M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
CVI Holdings deployed $154M of net new capital in Q2 2020, opening 53 new positions and adding to 2 existing holdings. Its largest new stake was Nikola Corporation Common Stock: 16,667 shares worth $33.8M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Enlivex Ltd, an estimated $1.96M trimmed.
- CVI Holdings's largest Q2 2020 buy was Nikola Corporation Common Stock: 16,667 shares worth $33.8M.
- CVI Holdings added most to Replimune Group in Q2 2020, an estimated $2.26M increase.
- CVI Holdings's biggest Q2 2020 reduction was Enlivex Ltd, cutting an estimated $1.96M.
- CVI Holdings fully exited DMK Pharmaceuticals Corporation Common Stock in Q2 2020, selling an estimated $1.21M.
- CVI Holdings's ten largest holdings make up 66% of its $270M portfolio in Q2 2020.
- CVI Holdings opened 53 new positions and closed 21 in Q2 2020.
- CVI Holdings's portfolio value rose 847% quarter-over-quarter to $270M.
Based on CVI Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.